Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of July 15, 2026, PDEX trades at $58.62 with a market cap of $196.51M and a P/E ratio of 17.06. PDEX moved -4.22% today. Year to date, PDEX is +51.40%; over the trailing twelve months it is +26.02%. Its 52-week range spans $23.47 to $70.26. Analyst consensus is buy with an average price target of $70.00. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PDEX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $58.62 |
| Market Cap | $196.51M |
| P/E Ratio | 17.06 |
| EPS | $3.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $70.26 |
| 52-Week Low | $23.47 |
| Volume | 36.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $72.10M |
| Net Income | $2.52M |
| Gross Margin | 28.29% |
1 analysts cover PDEX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $70.00.